Please login to the form below

Not currently logged in
Email:
Password:

Clinuvel Pharmaceuticals

This page shows the latest Clinuvel Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Orphan drugs lead CHMP recommendations

Orphan drugs lead CHMP recommendations

Clinuvel's Scenesse is first drug set for European approval to treat rare intolerance to sunlight. ... Scenesse (afamelanotide), developed by Australian company Clinuvel Pharmaceuticals, was one of two orphan medicines for rare diseases recommended in

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Solaris Health

The beauty of detail: an effective, compelling medical communications campaign requires each component to be carefully planned, expertly crafted and...

Latest intelligence

DNA
Why precision medicine demands precision engagement
The speed of innovation brings its own challenges, says cloud computing expert...
Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...

Infographics